Search

everythinglearnresearchcommunity

for

Search:↓

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

5% minoxidil works better for hair growth than 1% minoxidil.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

Minoxidil foam promotes hair growth and reduces hair loss safely in men.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Hair loss greatly lowers perceived health in both genders, and hair transplant surgery notably improves this.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Taking a small dose of prednisone before menstruation can almost completely prevent premenstrual acne with few side effects.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.